Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusiness

Ipca Laboratories Q4 PAT may dip 12% YoY to Rs 141.9 cr: Prabhudas Lilladher

Net Sales are expected to increase by 14.6 percent Y-o-Y (down 10.7 percent Q-o-Q) to Rs 1,277 crore, according to Prabhudas Lilladher.

April 14, 2022 / 05:02 PM IST
Ipca Laboratories

Ipca Laboratories

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Prabhudas Lilladher has come out with its fourth quarter (January-March’ 22) earnings estimates for the Healthcare sector. The brokerage house expects Ipca Laboratories to report net profit at Rs 141.9 crore down 12% year-on-year (down 28% quarter-on-quarter).

Net Sales are expected to increase by 14.6 percent Y-o-Y (down 10.7 percent Q-o-Q) to Rs 1,277 crore, according to Prabhudas Lilladher.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 2.5 percent Y-o-Y (down 25.7 percent Q-o-Q) to Rs 221.2 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347